Navigation Links
Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting
Date:5/18/2009

en-label re-treatment portion of the trial.

At 24 weeks after the first re-treatment, ACR 20, 50 and 70 response rates for subjects in the group (n=40) that had initially received an 800 mg dose and were re-treated with 800 mg of TRU-015 were 70%, 40% and 23%, respectively. ACR 20, 50 and 70 response rates in the group that had received an initial 1,600 mg dose and were subsequently re-treated with 800 mg were 68%, 30% and 14%, respectively. The safety and PD effects after re-treatment were comparable to those seen after initial therapy.

Numeric reductions in the Disease Activity Score 28 (DAS28), the Health Assessment Questionnaire (HAQ), and C-reactive protein (CRP) seen at the end of the double-blind treatment period were maintained or continued to improve during the open-label re-treatment period.

Infusions were generally well-tolerated and no patient experienced a serious adverse event on the day of infusion. Eight patients (3%) enrolled in the trial experienced serious adverse events during the first re-treatment period. This is similar to observations made during the initial double-blind phase of the study (placebo 2%, 800 mg group 4%).

"We are encouraged to see such strong results upon re-treatment of trial participants with TRU-015," said Peter Thompson, M.D., FACP, president, CEO and chairman of Trubion. "TRU-015 is an important clinical candidate for Trubion and Wyeth. The positive data we've seen from the program to date demonstrate that TRU-015 may fill a distinct need for additional treatment options in the RA community. We look forward to the presentation of the full re-treatment data at the conference."

The full EULAR presentation will be available in the investor section of Trubion's website (http://investors.trubion.com/index.cfm
'/>"/>

SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Trubion Announces Dates for Fourth-Quarter and Year-Ended 2008 Earnings Conference Call
2. Trubion Pharmaceuticals Provides Announcement Dates for Third-Quarter and Nine Months Earnings Conference Call
3. Trubion Pharmaceuticals Announces Appointment of New Chief Medical Officer
4. Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call
5. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
6. Trubion Announces Presentations at Upcoming Investor Conferences
7. Lotus Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
8. NovaBay Pharmaceuticals, Inc. Reports First Quarter 2009 Financial Results
9. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
10. Jiangbo Pharmaceuticals, Inc. Announces Conference Call to Discuss Results for its Third Quarter of FY 2009
11. Jiangbo Pharmaceuticals, Inc. to Present at CCG IRs China Rising Conference in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... By Alan Mozes ... -- Pediatricians, take note: Many American parents are aware of ... to choose a pediatrician for their children, according to a ... from more than 1,600 parents -- further suggest that negative ... if that doctor has been recommended by a neighbor. ...
(Date:9/22/2014)... partner in the Global STEM Alliance, a new high-tech ... science, technology, engineering and math (STEM) around the world. ... (NYAS), Malaysian Prime Minister Najib Razak participated in the ... the goal of developing over 1,000,000 aspiring STEM leaders ... will create a host of learning opportunities, including student ...
(Date:9/22/2014)... 22, 2014 An inventor and anesthesiologist ... the problem of side-sleeping. "My lower arm always became ... designed a solution to this problem," she said. "It’s ... to have your arm 'fall asleep.'" , The Sleeping ... her side more comfortably. It avoids pain and restlessness ...
(Date:9/22/2014)... Quincy Bioscience, one of the fastest-growing ... National Self-Improvement Month this September. The Wisconsin-based ... access to self-improvement resources, especially for maintaining healthy ... products that preserve health is growing as Americans ... six years, Quincy Bioscience has been promoting the ...
(Date:9/22/2014)... The Workgroup for Electronic ... authority on the use of health IT to ... from its recent industry survey on the use ... electronic transactions adopted under the Health Insurance Portability ... from August 20 to September 5, which included ...
Breaking Medicine News(10 mins):Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 2Health News:Many Parents Use Online Ratings to Pick a Pediatrician, Study Finds 3Health News:Growing scientists: World's future jobs are rooted in STEM 2Health News:Growing scientists: World's future jobs are rooted in STEM 3Health News:Quincy Bioscience Promotes National Self-Improvement Month 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3
... can be predicted with the use of diffusion-weighted MRI ... at New York University Medical Center in New York, ... chronic hepatitis in the United States, particularly hepatitis C, ... replace or supplement liver biopsy, which is relatively invasive ...
... Allscripts (Nasdaq: MDRX ),the leading provider of ... to improve healthcare, announced today that,it will report ... ended September,30, 2007 after the stock market closes ... Standard Time on the same day, Allscripts management ...
... Oct. 23 After five,successful years of steady ... today that it is celebrating five years of,continued ... sales growth,that indicates reaching 100,000 orders by the ... ), "Our ReBuilder for Diabetic Peripheral Neuropathy ...
... YORK, October 23 Answers.com(TM) (NASDAQ:,ANSW) ... interactive health education,videos from HealthiNation, a ... health content on Answers.com. (See example ... to consumers in categories such as ...
... more information, more, expertise and more options in their ... Oct. 23 As more than 7,000 leaders and,providers ... Meeting and Exposition,of the American Association of Homes and ... in Orlando, Florida, to explore the future of aging,services, ...
... between parents ... and teens, INDIANAPOLIS, ... at preventing drunk driving and,underage drinking with new 30-second radio public service ... timed to,coincide with the busy fall season and will air 2,300 times ...
Cached Medicine News:Health News:MRI predicts liver fibrosis, study says 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 2Health News:Allscripts to Announce Third Quarter 2007 Results on November 8th 3Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 2Health News:ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment 3Health News:Answers.com Adds HealthiNation Video Content to Answer Engine(TM) 2Health News:'Will You Still Love Me, Will You Still Need Me, When I'm 84?' 2Health News:Indiana Attorney General Steve Carter Addresses Drunk Driving and Underage Drinking in New Radio Campaign 2
(Date:9/22/2014)... , Sept. 22, 2014  Aethlon Medical, Inc. ... devices to address infectious disease, cancer and other ... Research Projects Agency (DARPA) has informed the Company ... proceed with year four of a five-year $5.9 ... September 30, 2011 under DARPA,s Dialysis-Like Therapeutics (DLT) ...
(Date:9/22/2014)... , Sept. 22, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... quarter and fiscal 2014 ended July 31, 2014 on Monday, ... call to discuss the results at 11:00 AM ET. Participating ... Chairman; Andrew A. Krakauer , President and CEO; ... Craig A. Sheldon , Senior Vice President, CFO and Treasurer; ...
(Date:9/22/2014)... SAN FRANCISCO , Sept. 22, 2014  Sutro ... FierceBiotech as one of 2014,s Fierce 15 ... promising private biotechnology companies in the industry.  ... A-list group of backers as well as industry partners ... developing antibody-drug conjugates and bispecifics," says John Carroll ...
Breaking Medicine Technology:Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3
... March 22 Cambrex Corporation (NYSE: ... a privately held company that is a leader in ... Wiesbaden, Germany and offers cost effective customized ... pharmaceutical industry, with the ability to utilize its tool ...
... Inc. (OTC Bulletin Board: GOVX), a biotechnology company that is developing and testing innovative HIV/AIDS vaccines, has engaged The Investor Relations Group ("IRG"), ... , ... , ... ...
Cached Medicine Technology:Cambrex Acquires IEP GmbH 2Cambrex Acquires IEP GmbH 3GeoVax Labs Engages The Investor Relations Group 2GeoVax Labs Engages The Investor Relations Group 3GeoVax Labs Engages The Investor Relations Group 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: